TABLE 2

Patients with Negative CI Findings

Patient no.	Sex	Age (y)	H	PT	Stage	TCD (GBq)	TSH* on T₄	Tg^† on T₄	TSH* off T₄	Tg^† off T₄	FDG PET results (n)	Histopathology	FU TSH*	FU Tg^†
1	F	27	P	T3	I	7.4	0.5	7.9	50	80	CLN (1)	Positive (S)	<0.02	<0.6
2	M	47	P	T2	II	11.1	0.23	3.1	61	43	CLN (1)	Positive (S)	0.04	<0.3
3	F	27	P	T4	I	11.1	0.02	1.5	200	60	Negative	ND	1	6.5
4	M	48	P	T4	III	7.4	0.6	6.7	>50	285	CLN (1)	Positive (S)	<0.05	<0.6
5	F	36	P	T2	I	14.8	0.58	15	115	83	CLN (5)	Positive (S)	2	4.5
6	M	29	P	T3	II	7.4	0.29	10	285	69	Negative	ND	0.5	50
7	F	50	FC	T4	III	11.1	0.3	92	88	1,560	CLN (5), lung (+)	Positive (S)	0.05	<0.6
8	M	76	P	T4	IV	7.4	0.8	60	47	500	Lung (+)	Positive (B)	2.3	100 (Ext rad)
9	F	63	P	T4	III	7.4	0.08	25	102	80	CLN (2)	Positive (S)	<0.05	60
10	M	53	FC	T4	III	11.1	0.1	41	50	435	CLN (1)	Positive (S)	0.3	<0.3
11	M	39	P	T3	I	14.8	0.04	2.3	60	129	Negative	ND	ND	ND
12	F	37	P	T2	I	14.8	0.03	10	43	121	CLN (1)	Inflamed lymph nodes (S)	>50	60
13	F	62	P	T1	IV	22.2	0.05	43	61	415	Negative	ND	0.4	45
14	F	45	P	T4	III	7.4	0.06	2.8	48	30	CLN (3)	Inflamed lymph nodes (S)	<0.05	5
15	M	38	FC	T3	I	11.1	0.2	110	113	19,000	Bone (2)	Positive (S)	0.02	154
16	F	55	P	T3	III	11.1	0.07	55	110	178	CLN (2)	Inflamed lymph nodes (S)	<0.04	28
17	M	37	P	T3	I	11.1	0.43	15	44	93	Negative	ND	0.43	2
18	M	72	FC	T3	III	7.4	0.2	3	28	40	CLN (1), MLN (2)	Positive (S)	<0.05	<0.6
19	M	31	P	T3	I	14.8	0.4	1.5	176	37	Negative	ND	ND	ND
20	F	63	HC	T4	III	7.4	0.6	200	136	10,000	MLN (2)	Positive (S)	0.05	800
21	M	72	P	T3	IV	14.8	0.66	8	49	53	Bone (1)	Positive (S)	ND	Deceased
22	F	32	P	T3	I	7.4	0.01	1.5	60	113	CLN (2)	Positive (S)	<0.05	<0.6
23	F	78	HC	T4	III	7.4	0.13	2,800	78	22,100	Lung (+)	ND	0.10	2,000
24	M	40	FC	T4	I	7.4	0.01	30	196	800	Negative	ND	0.11	20
25	F	50	P	T2	II	11.1	0.5	39	144	105	CLN (1)	Positive (S)	<0.02	<0.6
26	F	35	P	T1	I	7.4	0.31	1.5	150	33	Negative	ND	0.2	2.5
27	M	28	P	T3	I	7.4	3.2	20	107	270	CLN (2)	Positive (S)	02	<0.6

↵*Data in mU/L.
↵^†Data in μg/L.
H = histology of thyroid carcinoma; PT = primary tumor stage; TCD = total cumulative dose; T₄ = l-thyroxine; FU = follow-up; P = papillary carcinoma; CLN = cervical lymph node; S = surgery; ND = not done; FC = follicular carcinoma; + = multiple; B = biopsy; Ext rad = external radiation; MLN = mediastinal lymph node; HC = Hürthle-cell carcinoma.